MYD88 and neoplasm: In another study, inoculation of IL-33-expressing EL4, CT26 or B16.F10 tumor cells induced MyD88-dependent intratumoral expansion of ILC2 in mice that were indispensable for IL-33-mediated antitumor activity independently of eosinophils (83).